
THURSDAY, Nov. 3, 2022 (HealthDay News) – A weight-loss drug approved for adults may soon become an option for teens struggling with obesity. Young people who received the drug Wegovy (semaglutide) were able to lose an average of 14.7% of their starting body weight in a new clinical trial. More than 40% of the youths… read on > read on >